Analyst Moves: LLY, UHS

Posted on October 11, 2012 at 15:15 PM EDT

Eli Lilly (LLY) had its price target raised by Bank of America/Merrill Lynch (BAC) as the company should benefit from the sale of its Sola drug to treat Alzheimer's. A $57 price target was issued with a buy rating.

Related Stocks:

Bank of America Corp. Credit Suisse Group ADS Eli Lilly & Co. Universal Health Services Inc. Cl B

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates